GlaxoSmithKline Pharmaceuticals share news, announcements and annual reports
NSE: GLAXOBSE: 500660Pharmaceuticals & BiotechnologyMid Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹2,515.10.
30 Oct: open ₹2,527.60, high ₹2,528.90, low ₹2,479.30
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹42,255 Cr221st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 39.56
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 18.64
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.29%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 50.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 56.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 56,34965.0% delivered
GlaxoSmithKline Pharmaceuticals board meetings
114 filed, newest first. Page 1 of 3.
Oct 2026
13 Oct · Board meeting
Jul 2026
21 Jul · Board meeting
Apr 2026
Mar 2026
2 Mar · Board meeting
Jan 2026
6 Jan · Board meeting
Oct 2025
27 Oct · Board meeting
Jul 2025
4 Jul · Board meeting
Apr 2025
Mar 2025
26 Mar · Board meeting
Feb 2025
14 Feb · Board meeting
14 Feb · Board meeting
Jan 2025
15 Jan · Board meeting
Not held on this date
Oct 2024
Jul 2024
17 Jul · Board meeting
Apr 2024
Jan 2024
4 Jan · Board meeting
Nov 2023
9 Nov · Board meeting
Oct 2023
Jul 2023
26 Jul · Board meeting
Jun 2023
29 Jun · Board meeting
May 2023
Jan 2023
11 Jan · Board meeting
Oct 2022
17 Oct · Board meeting
Jun 2022
May 2022
Feb 2022
7 Feb · Board meeting
Dec 2021
28 Dec · Board meeting
Oct 2021
29 Oct · Board meeting
Sep 2021
27 Sep · Board meeting
Jul 2021
26 Jul · Board meeting
26 Jul · Board meeting
6 Jul · Board meeting
May 2021
18 May · Board meeting
Feb 2021
Jan 2021
7 Jan · Board meeting
Oct 2020
28 Oct · Board meeting
Sep 2020
Jul 2020
1 Jul · Board meeting
May 2020
18 May · Board meeting
Feb 2020
3 Feb · Board meeting
Dec 2019
27 Dec · Board meeting
Oct 2019
22 Oct · Board meeting
Sep 2019
Jul 2019
22 Jul · Board meeting